High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients-Reference-Cited by-同舟云学术

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients

Published:2022-05 Issue: Volume:129 Page:102827
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Fabris Martina,De Marchi Ginevra,Domenis Rossana,Caponnetto Federica,Guella Silvia,Dal Secco Chiara,Cabas Nicola,De Vita Salvatore,Beltrami Antonio Paolo,Curcio Francesco,Quartuccio Luca^ORCID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference30 articles.

1. C4591001 clinical trial group, safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N. Engl. J. Med.,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

3. COVID-19 Global Rheumatology Alliance, Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry;Gianfrancesco;Ann. Rheum. Dis.,2020

4. COVID-19 Global Rheumatology Alliance, Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry;Strangfeld;Ann. Rheum. Dis.,2021

5. American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3;Curtis;Arthritis Rheumatol.,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study;Vaccine;2024-10

2. The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment;Frontiers in Immunology;2024-09-04

3. Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases;Vaccines;2024-03-06

4. Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis;Vaccines;2023-09-04

5. Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study;RMD Open;2023-08